生物讯号撷取系统市场规模、份额和成长分析：按组件、讯号类型、系统类型、应用、最终用户、连接方式和地区划分 - 2026-2033 年产业预测

2024年全球生物讯号采集系统市值为5.489亿美元，预计将从2025年的6.1916亿美元成长到2033年的16.2284亿美元。预测期（2026-2033年）的复合年增长率预计为12.8%。

全球生物讯号采集系统市场的发展动力源自于临床和消费领域对精准、连续生理监测日益增长的需求。这些系统能够撷取心电图 (ECG)、脑电图 (EEG) 和肌电图 (EMG) 等多种生理讯号，从而实现诊断和远端患者监护。早期发现并持续追踪健康状况可显着降低住院率，并有助于制定个人化治疗方案。在感测器技术进步的推动下，市场正从大型医院级设备转向紧凑型、基于云端分析的无线设备。微型感测器与先进连接技术的融合正在推动市场扩张，催生出能够提醒医护人员注意危险状况并改善诊断通讯协定的设备。此外，人工智慧透过先进的降噪和特征提取技术提升讯号质量，优化数据分析，有助于改善医疗效果。

全球生物讯号撷取系统市场驱动因素

远端患者监护计画的激增显着推动了对生物讯号采集系统的需求，这些系统能够在传统医院环境之外，实现生理数据的连续、非侵入性采集。医疗服务提供者正致力于开发能够全面追踪关键健康指标（例如心率、呼吸模式和电生理讯号）的技术，这些指标对于慢性病管理和降低再入院风险至关重要。为此，製造商正在不断改进感测器整合、无线功能以及与各种临床平台的兼容性等特性。这种对远端医疗的关注正在拓展部署的可能性，加快采购流程，并推动对支持以患者为中心的医疗模式的灵活采集解决方案的投资。

全球生物讯号撷取系统市场的限制因素

全球生物讯号采集系统市场面临许多挑战，主要源自于医疗设备和软体相关监管要求的复杂性和不断变化。这些法规透过延长产品开发週期和增加遵循成本，对开发商构成了阻碍。製造商必须应对区域差异化的核准流程，遵守严格的资料安全和病患安全标准，并进行全面的临床检验，以满足监管机构和付款方的期望。此外，大量的文件工作，以及上市后监测和互通性测试的要求，可能会阻碍中小企业进入该市场，最终影响创新生物讯号撷取技术在临床应用中的及时推广。

生物讯号采集系统的全球市场趋势

全球生物讯号采集系统市场正经历着向穿戴式远端监测解决方案的显着转变。这正推动着医疗模式向去中心化模式的根本性变革，该模式强调对病人的持续观察。舒适性高的设备有助于提高用户依从性，并能与远距远端医疗平台无缝集成，从而促进慢性病的积极管理和復健。医疗服务提供者与技术合作伙伴之间日益紧密的协作，正在推动可互通的医疗路径的开发，这些路径优先考虑患者体验、安全的数据传输和远端临床决策支援。因此，这一趋势正在促进生物讯号监测在临床和消费市场中得到更广泛的应用。

目录

介绍

• 调查目的
• 市场定义和范围

调查方法

• 研究过程
• 二级资料和一级资料的方法
• 市场规模估算方法

执行摘要

• 全球市场展望
• 市场主要亮点
• 细分市场概览
• 竞争环境概述

市场动态及展望

• 总体经济指标
• 促进者和机会
• 抑制因素和挑战
• 供给面趋势
• 需求面趋势
• 波特的分析和影响

市场考察

• 关键成功因素
• 影响市场的因素
• 主要投资机会
• 生态系测绘
• 2025年市场吸引力指数
• PESTEL 分析
• 监理情势
• 技术分析

全球生物讯号撷取系统市场规模：按组件和复合年增长率划分（2026-2033 年）

• 硬体
  • 感测器和电极
  • 扩大机
  • 资料收集单元
  • 信号调理装置
• 软体
  • 讯号处理软体
  • 数据分析和视觉化软体
• 服务

全球生物讯号撷取系统市场规模：按讯号类型和复合年增长率划分（2026-2033 年）

• 心电图（ECG）
• 脑电图（EEG）
• 肌电图（EMG）
• 功能性近红外线光谱（fNIRS）
• 脑磁图（MEG）
• 眼电图（EOG）
• 呼吸讯号
• 其他的

全球生物讯号撷取系统市场规模：按系统类型和复合年增长率划分（2026-2033 年）

• 穿戴式装置
  • 智慧型手錶
  • 穿戴式感测器
• 非穿戴式系统

全球生物讯号撷取系统市场规模：按应用和复合年增长率划分（2026-2033 年）

• 临床诊断
• 病患监测
• 研究和学术用途
• 居家医疗
• 运动与健身监测
• 神经復健

全球生物讯号撷取系统市场规模：依最终用户和复合年增长率划分（2026-2033 年）

• 医院
• 专科诊所
• 诊断检查室
• 学术和研究机构
• 生物技术和製药公司
• 居家医疗环境
• 运动健身中心

全球生物讯号撷取系统市场规模：连结方式、性别及复合年增长率（2026-2033）

• 有线系统
• 无线系统

全球生物讯号撷取系统市场规模及复合年增长率（2026-2033）

• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场公司采取的策略
• 近期市场趋势
• 企业市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 按细分市场进行企业市占率分析
  • 2023-2025年营收年比比较

主要企业简介

• BioSignal Technologies
• Cognevo
• NeuroSky
• MEDLITE
• BioTrace
• BrainVision
• Thought Technology
• MindMedia
• Advantech
• VitalConnect
• Neuroelectrics
• Zeto
• BioSensics
• Emotiv
• g.tec medical engineering
• eVokai
• Nexus Bioengineering
• Aesculap Meditec
• Synapse Biomedical
• AliveCor

结论与建议

Global Biosignal Acquisition System Market size was valued at USD 548.9 Million in 2024 and is poised to grow from USD 619.16 Million in 2025 to USD 1622.84 Million by 2033, growing at a CAGR of 12.8% during the forecast period (2026-2033).

The global biosignal acquisition system market is driven by an increasing need for precise and continuous physiological monitoring in both clinical and consumer environments. These systems capture various physiological signals such as ECG, EEG, and EMG, facilitating diagnostics and remote patient monitoring. Early detection and ongoing tracking of health conditions significantly lower hospitalization rates and promote personalized treatment plans. The market has transitioned from bulky hospital apparatus to compact, wireless devices bolstered by cloud analytics, attributed to advancements in sensor technology. The fusion of miniaturized sensors and advanced connectivity propels market expansion, yielding devices that alert healthcare providers to critical conditions and refine diagnostic protocols. Furthermore, AI enhances signal quality through sophisticated noise reduction and feature extraction, thereby optimizing data analysis for improved healthcare outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biosignal Acquisition System market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biosignal Acquisition System Market Segments Analysis

Global biosignal acquisition system market is segmented by component, signal type, system type, application, end user, connectivity and region. Based on component, the market is segmented into Hardware, Software and Services. Based on signal type, the market is segmented into Electrocardiogram (ECG), Electroencephalogram (EEG), Electromyography (EMG), Functional Near-Infrared Spectroscopy (fNIRS), Magnetoencephalography (MEG), Electrooculography (EOG), Respiratory Signals and Others. Based on system type, the market is segmented into Wearable Devices and Non-Wearable Systems. Based on application, the market is segmented into Clinical Diagnostics, Patient Monitoring, Research & Academic Use, Home Healthcare, Sports & Fitness Monitoring and Neurorehabilitation. Based on end user, the market is segmented into Hospitals, Specialty Clinics, Diagnostic Laboratories, Academic & Research Institutes, Biotechnology & Pharmaceutical Companies, Homecare Settings and Sports & Fitness Centers. Based on connectivity, the market is segmented into Wired Systems and Wireless Systems. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biosignal Acquisition System Market

The surge in remote patient monitoring initiatives is significantly boosting the demand for biosignal acquisition systems, as they facilitate the continuous and noninvasive gathering of physiological data beyond traditional hospital settings. Healthcare providers are increasingly focused on technologies that enable comprehensive tracking of key health indicators, such as heart rate, breathing patterns, and electrophysiological signals, crucial for managing chronic diseases and minimizing the likelihood of readmissions. In response, manufacturers are enhancing aspects like sensor integration, wireless functionality, and compatibility with various clinical platforms. This heightened emphasis on remote care broadens deployment possibilities, accelerates purchasing processes, and fosters investment in flexible acquisition solutions that support patient-centered healthcare models.

Restraints in the Global Biosignal Acquisition System Market

The Global Biosignal Acquisition System market faces significant challenges due to complex and continuously changing regulatory requirements related to medical devices and software. These regulations create barriers for developers by prolonging the product development process and raising compliance expenses. Manufacturers must negotiate various approval processes in different regions, adhere to strict data security and patient safety standards, and conduct thorough clinical validation to meet the expectations of regulators and payers. Additionally, the extensive documentation needed, along with demands for post-market surveillance and interoperability testing, can discourage smaller companies, ultimately hindering the timely introduction of innovative biosignal acquisition technologies into clinical use.

Market Trends of the Global Biosignal Acquisition System Market

The Global Biosignal Acquisition System market is witnessing a significant trend towards wearable remote monitoring solutions, fundamentally transforming care delivery into a decentralized model that emphasizes continuous patient observation. This shift facilitates proactive management of chronic conditions and rehabilitation, as devices designed for comfort enhance user adherence and seamlessly integrate with telemedicine platforms. Increased collaboration between healthcare providers and technology partners is leading to the development of interoperable care pathways that prioritize patient experience, secure data transmission, and remote clinical decision support. Consequently, this trend is fostering broader acceptance of biosignal monitoring across both clinical settings and consumer markets.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Technology Analysis

Global Biosignal Acquisition System Market Size by Component & CAGR (2026-2033)

• Market Overview
• Hardware
  • Sensors & Electrodes
  • Amplifiers
  • Data Acquisition Units
  • Signal Conditioning Devices
• Software
  • Signal Processing Software
  • Data Analysis & Visualization Software
• Services

Global Biosignal Acquisition System Market Size by Signal Type & CAGR (2026-2033)

• Market Overview
• Electrocardiogram (ECG)
• Electroencephalogram (EEG)
• Electromyography (EMG)
• Functional Near-Infrared Spectroscopy (fNIRS)
• Magnetoencephalography (MEG)
• Electrooculography (EOG)
• Respiratory Signals
• Others

Global Biosignal Acquisition System Market Size by System Type & CAGR (2026-2033)

• Market Overview
• Wearable Devices
  • Smartwatches
  • Wearable Sensors
• Non-Wearable Systems

Global Biosignal Acquisition System Market Size by Application & CAGR (2026-2033)

• Market Overview
• Clinical Diagnostics
• Patient Monitoring
• Research & Academic Use
• Home Healthcare
• Sports & Fitness Monitoring
• Neurorehabilitation

Global Biosignal Acquisition System Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialty Clinics
• Diagnostic Laboratories
• Academic & Research Institutes
• Biotechnology & Pharmaceutical Companies
• Homecare Settings
• Sports & Fitness Centers

Global Biosignal Acquisition System Market Size by Connectivity & CAGR (2026-2033)

• Market Overview
• Wired Systems
• Wireless Systems

Global Biosignal Acquisition System Market Size & CAGR (2026-2033)

• North America (Component, Signal Type, System Type, Application, End User, Connectivity)
  • US
  • Canada
• Europe (Component, Signal Type, System Type, Application, End User, Connectivity)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Component, Signal Type, System Type, Application, End User, Connectivity)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Component, Signal Type, System Type, Application, End User, Connectivity)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Component, Signal Type, System Type, Application, End User, Connectivity)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• BioSignal Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cognevo
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroSky
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MEDLITE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioTrace
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BrainVision
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thought Technology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MindMedia
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advantech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VitalConnect
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuroelectrics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zeto
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioSensics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emotiv
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• g.tec medical engineering
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• eVokai
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nexus Bioengineering
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aesculap Meditec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synapse Biomedical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AliveCor
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations